Arteris director gets stock as board retainer

Q: What insider transaction did Joachim Kunkel report for Arteris (AIP)?

Joachim Kunkel, a director of Arteris, Inc., reported acquiring 910 shares of Arteris common stock on January 5, 2026 as a Form 4 insider transaction.

Q: At what price were the 910 Arteris (AIP) shares recorded on the Form 4?

The 910 shares of Arteris common stock were reported at a price of $0.00 per share, indicating they were received as compensation rather than purchased in the market.

Q: Why did the Arteris (AIP) director receive 910 shares instead of cash?

The filing states that the restricted stock represents retainer fees that the reporting person elected to receive in the form of shares of common stock in lieu of cash.

Q: How many Arteris (AIP) shares does Joachim Kunkel own after this transaction?

After the reported grant, Joachim Kunkel beneficially owned 68,728 shares of Arteris common stock, held in direct ownership.

Q: What does it mean that the Arteris (AIP) restricted stock is fully vested?

The footnote explains that it is fully vested restricted stock, meaning the shares are not subject to additional vesting conditions, even though the reporting person elected to defer the receipt of shares.

Q: What role does Joachim Kunkel have at Arteris (AIP) according to the Form 4?

The Form 4 identifies Joachim Kunkel as a director of Arteris, Inc. and does not mark him as a 10% owner or officer.

Arteris, Inc. director Joachim Kunkel reported receiving 910 shares of common stock as fully vested restricted stock on January 5, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Arteris, Inc. director Joachim Kunkel reported receiving 910 shares of common stock as fully vested restricted stock on January 5, 2026. These shares represent retainer fees that he elected to take in stock instead of cash. The shares were acquired at a stated price of $0.00 per share, reflecting their nature as compensation rather than an open-market purchase. After this grant, Kunkel beneficially owned 68,728 shares of Arteris common stock in direct ownership. He also elected to defer the receipt of the shares, indicating that while the award is fully vested, delivery of the stock is postponed under a deferral arrangement.

Insider Trade Summary

Grant/Award: 910 shares

Grant/Award 1 txn

Insider Kunkel Joachim

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	910	$0.00	$0.00

Holdings After Transaction: Common Stock — 68,728 shares (Direct)

Footnotes (2)

F1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
F2. The Reporting Person elected to defer the receipt of shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Joachim Kunkel report for Arteris (AIP)?

Joachim Kunkel, a director of Arteris, Inc., reported acquiring 910 shares of Arteris common stock on January 5, 2026 as a Form 4 insider transaction.

At what price were the 910 Arteris (AIP) shares recorded on the Form 4?

The 910 shares of Arteris common stock were reported at a price of $0.00 per share, indicating they were received as compensation rather than purchased in the market.

Why did the Arteris (AIP) director receive 910 shares instead of cash?

The filing states that the restricted stock represents retainer fees that the reporting person elected to receive in the form of shares of common stock in lieu of cash.

How many Arteris (AIP) shares does Joachim Kunkel own after this transaction?

After the reported grant, Joachim Kunkel beneficially owned 68,728 shares of Arteris common stock, held in direct ownership.

What does it mean that the Arteris (AIP) restricted stock is fully vested?

The footnote explains that it is fully vested restricted stock, meaning the shares are not subject to additional vesting conditions, even though the reporting person elected to defer the receipt of shares.

What role does Joachim Kunkel have at Arteris (AIP) according to the Form 4?

The Form 4 identifies Joachim Kunkel as a director of Arteris, Inc. and does not mark him as a 10% owner or officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 01/07/2026 - 06:07 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kunkel Joachim

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

95008

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/05/2026		A		910⁽¹⁾⁽²⁾	A	$0.00	68,728	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.

2. The Reporting Person elected to defer the receipt of shares.

Remarks:

	/s/ Paul Alpern as Attorney-in-fact for Joachim Kunkel	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR